Khodadadi Hossein, Mirhendi Hossein, Mohebali Mehdi, Kordbacheh Parivash, Zarrinfar Hossein, Makimura Koichi
Dept. of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Iran J Public Health. 2013 Mar 1;42(3):298-305. Print 2013.
Pneumocystis jirovecii causes Pneumocystis pneumonia (PCP) in immunocompromised patients with a high rate of morbidity and mortality. Colonization with this fungus may stimulate pulmonary inflammation or lead to PCP in susceptible patients. The epidemiology of this infection and routs of its transmission has poorly studied in Iran. We examined Pneumosystis colonization in patients with various lung underlying diseases.
Bronchoalveolar lavage (BAL) fluids of 458 patients with different underlying diseases or pulmonary signs were collected between August 2010 and January 2012. Patients were divided into four groups: transplant recipients, malignant patients, immunosuppressive drug recipients and patients with other different lung diseases. A sensitive nested-PCR method targeted 18S ribosomal RNA gene was used for investigating P. jirovecii in the specimens.
P. jirovecii DNA was detected in 57 out of 458 (12.5%) BAL samples by nested-PCR. Colonization rate in malignant patients, transplant recipients, immunosuppressive therapy recipients and patients with other various lung diseases was 21.7%, 20.3%, 12.7% and 7.3%, respectively. The enzyme BanI cuts all PCR products producing fragments with the size of 228 and 104 base pair. This finding as well as sequencing of four random positive samples validated and reconfirmed the PCR results. P. jirovecii cysts were found in 5 out of 57 PCR positive samples.
A significant number of patients with pulmonary diseases were colonized by P. jirovecii that can develop to PCP in these patients or they may transmit the fungus to other susceptible patients.
耶氏肺孢子菌可导致免疫功能低下患者发生肺孢子菌肺炎(PCP),发病率和死亡率很高。这种真菌的定植可能会刺激肺部炎症,或导致易感患者发生PCP。在伊朗,这种感染的流行病学及其传播途径研究较少。我们研究了患有各种肺部基础疾病患者的肺孢子菌定植情况。
2010年8月至2012年1月期间,收集了458例患有不同基础疾病或肺部症状患者的支气管肺泡灌洗(BAL)液。患者分为四组:移植受者、恶性肿瘤患者、免疫抑制药物接受者和患有其他不同肺部疾病的患者。采用针对18S核糖体RNA基因的敏感巢式PCR方法检测标本中的耶氏肺孢子菌。
通过巢式PCR在458份BAL样本中的57份(12.5%)中检测到耶氏肺孢子菌DNA。恶性肿瘤患者、移植受者、免疫抑制治疗接受者和患有其他各种肺部疾病患者的定植率分别为21.7%、20.3%、12.7%和7.3%。酶BanI切割所有PCR产物,产生大小为228和104碱基对的片段。这一发现以及对四个随机阳性样本的测序验证并再次确认了PCR结果。在57份PCR阳性样本中的5份中发现了耶氏肺孢子菌囊肿。
大量肺部疾病患者被耶氏肺孢子菌定植,这些患者可能发展为PCP,或者他们可能将真菌传播给其他易感患者。